Publications
- Neural multiplexing vs place coding: Multiplexing steps in when most needed Leeman, J.M., Willett, S.M., Marco, N., et al. bioRxiv preprint, 2026.
- Adaptive Generalized Elliptical Slice Sampling Marco, N., Tokdar, S.T. arXiv preprint, 2026.
- Mixed Membership Models for Multilevel Functional Data Telesca, D., Marco, N., Landry, E. arXiv preprint, 2026.
- Covariate Adjusted Functional Mixed Membership Models Marco, N., Şentürk, D., Jeste, S., et al. Statistics and Data Science in Imaging, 2025.
- Germline microRNA-based signatures predict toxicity and response to anti-CTLA-4 therapy Weidhaas, J.B., McGreevy, K.M., Marco, N., et al. Journal of Translational Medicine, 2025.
- Bayesian Covariance Regression in Functional Data Analysis with Applications to Functional Brain Imaging Shamshoian, J., Marco, N., Şentürk, D., et al. The International Journal of Biostatistics, 2025.
- Modeling Neural Switching via Drift-Diffusion Models Marco, N., Groh, J.M., Tokdar, S.T. arXiv preprint, 2024.
- Flexible Regularized Estimation in High-Dimensional Mixed Membership Models Marco, N., Şentürk, D., Jeste, S., et al. Computational Statistics & Data Analysis, 2024.
- Functional Mixed Membership Models Marco, N., Şentürk, D., Jeste, S., et al. Journal of Computational and Graphical Statistics, 2024.
- Early findings from the GARUDA trial: The impact of a genetic signature of late radiation toxicity on prostate cancer treatment decision making Weidhaas, J.B., Marco, N., Steinberg, M.L., et al. Journal of Clinical Oncology, 2023.
- Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial Kishan, A.U., Marco, N., Ma, T.M., et al. Clinical and Translational Radiation Oncology, 2023.
- Viral burden and clearance in asymptomatic COVID-19 Patients Gunatilaka, A.B., Marco, N., Read, G.H., et al. Open forum infectious diseases, 2022.
- Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy Weidhaas, J., Marco, N., Scheffler, A.W., et al. Journal for immunotherapy of cancer, 2022.
- Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation Kishan, A.U., Marco, N., Schulz-Jaavall, M.B., et al. Radiotherapy and Oncology, 2022.